Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Change in Account Payables (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Change in Account Payables for 3 consecutive years, with -$150000.0 as the latest value for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 82.93% year-over-year to -$150000.0; the TTM value through Dec 2025 reached -$760000.0, down 246.44%, while the annual FY2025 figure was -$760000.0, 246.44% down from the prior year.
  • Change in Account Payables hit -$150000.0 in Q4 2025 for Artiva Biotherapeutics, up from -$442000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.6 million in Q3 2023 and bottomed at -$1.9 million in Q4 2023.
  • Average Change in Account Payables over 3 years is -$57700.0, with a median of -$116000.0 recorded in 2024.
  • Year-over-year, Change in Account Payables soared 95.73% in 2024 and then crashed 162.78% in 2025.
  • Artiva Biotherapeutics' Change in Account Payables stood at -$1.9 million in 2023, then skyrocketed by 95.73% to -$82000.0 in 2024, then plummeted by 82.93% to -$150000.0 in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$150000.0, -$442000.0, and -$209000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.